Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17305827 | 0.98 | — | — | |
| SCHEMBL17305842 | 0.96 | — | — | |
| SCHEMBL17305834 | 0.94 | — | — | |
| SCHEMBL17305710 | 0.93 | KDM4E (0.30) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL17297353 | 0.93 | KDM4E (0.30) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL17305728 | 0.93 | — | — | |
| SCHEMBL17305832 | 0.93 | — | — | |
| SCHEMBL17297629 | 0.92 | — | — | |
| SCHEMBL17297410 | 0.91 | — | — | |
| SCHEMBL17305714 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9570689-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2017-02-14 | — | — | US | disclosed |
| US-9570689-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2017-02-14 | — | — | US | disclosed |
| US-20160233433-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-08-11 | — | — | US | disclosed |
| US-20160233433-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-08-11 | — | — | US | disclosed |
| US-9331288-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-03 | — | — | US | disclosed |
| US-9331288-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-03 | — | — | US | disclosed |
| US-20150349272-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349272-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, ORAI2 | KDM4E 1106/4885ALDH1A1 693/4885MAPT 2247/4885 |
| US-20160233433-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, LEF1, TMEM109 | KDM4E 989/4885ALDH1A1 575/4885MAPT 3397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.